PROS1 and viral infectious disease: With the assumption described above, we infer that targeting SARS-CoV-2 binding to HSPGs may potentially interfere with virus infection as structurally defined heparin/UFH/LMWH, together with their mimetics might bind the S protein and function as a competitive inhibitor by competing with cell surface HSPGs to prevent viral adhesion, thus decreasing infectivity.